BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/13/2023 12:49:11 PM | Browse: 374 | Download: 1251
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 85241
Country India
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways
Manuscript Source Invited Manuscript
All Author List Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee and Nilabja Sikdar
Funding Agency and Grant Number
Funding Agency Grant Number
Department of Biotechnology, Government of India Grant Sanction, Ramalingaswami Re-entry Fellowship RLS/BT/Re-entry/05/2012
Corresponding Author Nilabja Sikdar, PhD, Academic Research, Associate Professor, Doctor, Doctor, Research Scientist, Human Genetics Unit, Indian Statistical Institute, Plot No, 203, Barrackpore Trunk Rd, Dunlop, Bonhooghly Government Colony, Kolkata 700108, West Bengal , India. snilabja@isical.ac.in
Key Words Methylation driven pathways; Pancreatic cancer methylation markers; signaling pathway targeted therapy; PanCa enriched methylated pathway; Pre-cancer methylated pathways
Core Tip Given the limited commercial availability of targeted epi-drugs and pathway-based biomarkers, it is important to generalize them for appropriate treatment of pancreatic cancer and related precancerous lesions. We also highlighted the clinical use of these therapeutic targets based on methylation driven pathways. This review will successfully help readers address current issues and support cutting-edge development of targeted therapies using epigenetically regulated pathways.
Publish Date 2023-09-13 09:17
Citation Bararia A, Das A, Mitra S, Banerjee S, Chatterjee A, Sikdar N. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. World J Gastrointest Oncol 2023; 15(9): 1505-1519
URL https://www.wjgnet.com/1948-5204/full/v15/i9/1505.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i9.1505
Full Article (PDF) WJGO-15-1505-with-cover.pdf
Full Article (Word) WJGO-15-1505.docx